News
TCON
1.890
+2.16%
0.040
Weekly Report: what happened at TCON last week (0415-0419)?
Weekly Report · 3d ago
INVO, EZGO and WISA among pre-market losers
Seeking Alpha · 04/18 12:15
12 Health Care Stocks Moving In Wednesday's After-Market Session
Trevena (NASDAQ:TRVN) shares increased by 27.0% to $0.51 during Wednesday's after-market session. Mustang Bio stock increased by 11.97% and SINTX Techs stock rose 10.32% in the same session. Losers TRACON Pharma and DIH Holding US stock fell by 16.6% and 14.05% respectively.
Benzinga · 04/17 20:31
Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
The Travelers Companies, Inc. Shares dipped 8.1% to $205.03 on Wednesday. Travelers reported a mixed first quarter, with earnings lagging analyst' expectations. InVO Bioscience shares shot up 256% after the company reported a year-over-year increase in fourth-quarter revenue.
Benzinga · 04/17 17:36
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Ultragenyx Pharmaceutical shares dipped 9.4% to $42.46 on Monday. The company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome. Soligenix, Inc. Shares surged 71.5% after the company was granted orphan drug designation for MarVax.
Benzinga · 04/15 18:11
12 Health Care Stocks Moving In Monday's Pre-Market Session
Soligenix (NASDAQ:SNGX) stock increased by 95.1% to $0.75 during Monday's pre-market session. The company's market cap stands at $7.9 million. Cartesian Therapeutics and Longeveron also moved upwards. Losers Marinus Pharma and PaxMedica stock decreased by more than 20%.
Benzinga · 04/15 12:07
Why Medical Properties Trust Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
Medical Properties Trust, Inc. Shares jumped 13.1% in today's pre-market trading. The company announced it sold its majority interest in Utah Hospitals. LendingClub Corporation is expected to report earnings for the first quarter 2024 after the closing bell on Tuesday. Allarity Therapeutics shares rose 51% to $3.17 in pre- market trading.
Benzinga · 04/15 09:45
Weekly Report: what happened at TCON last week (0408-0412)?
Weekly Report · 04/15 09:42
TRACON Pharmaceuticals files to sell common stocks, warrants
Seeking Alpha · 04/12 21:00
*TRACON Pharmaceuticals to Offer Stock
Dow Jones · 04/12 20:59
TRACON PHARMACEUTICALS FILES FOR OFFERING OF SHARES OF COMMON STOCK, PRE-FUNDED WARRANTS; SIZE NOT DISCLOSED - SEC FILING
Reuters · 04/12 20:55
Buy Rating Reaffirmed for TRACON Pharmaceuticals Post-Reverse Split and Envafolimab Valuation Update
TipRanks · 04/10 14:25
Aptevo Therapeutics, TRACON Pharmaceuticals, Biosig Technologies among healthcare movers
Healthcare On the Move: Aptevo Therapeutics, TRACON Pharmaceuticals, Biosig Technologies among healthcare movers. S&P 500 Health Care Sector -1.07% to 1653.22. Adial Pharmaceuticals (ADIL) and iCoreConnect (ICCT) are among the biggest gainers.
Seeking Alpha · 04/10 14:02
Why Agenus Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Agenus Inc. (NASDAQ:AGEN) fell sharply during Monday's session. Auddia Inc. Shares jumped 231.7% to $4.72. The company announced a 1-for-20 reverse stock split of common stock.
Benzinga · 04/08 17:10
Shares of Tracon Pharmaceuticals Tumble 22% on Reverse Split
Shares of Tracon Pharmaceuticals fell 22% to 20 cents in midday trading on Monday. The company said it would enact a 1-for-20 reverse stock split. Shares have dropped about 90% in the last year. Tracon is a biotechnology company developing cancer treatments.
Dow Jones · 04/08 17:07
TRACON PHARMACEUTICALS INC - BOARD TODAY APPROVED A REVERSE STOCK SPLIT OF COMPANY'S COMMON STOCK AT A RATIO OF ONE-FOR-TWENTY
Reuters · 04/08 13:10
Weekly Report: what happened at TCON last week (0401-0405)?
Weekly Report · 04/08 09:44
Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Ulta Beauty shares dipped 13.7% to $448.08 on Wednesday. The company reportedly issued a weak outlook at the J.P. Morgan Retail Roundup investor conference. ARCA biopharma, Inc. Shares climbed 108% in the mid-day session.
Benzinga · 04/03 17:56
Tracon Pharma drops after pivotal data for cancer drug
Shares of Tracon Pharmaceuticals dropped sharply after early data from the company’s pivotal ENVASARC Phase 2 trial for its cancer therapy. Tracon Pharma drops after pivotal data for cancer drug envafolimab disappointed investors. The drug led to an objective response rate of 6% and median duration of response of six months.
Seeking Alpha · 04/03 17:52
Tracon Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 04/03 16:32
More
Webull provides a variety of real-time TCON stock news. You can receive the latest news about Tracon Pharmaceu through multiple platforms. This information may help you make smarter investment decisions.
About TCON
TRACON Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of novel targeted therapeutics for cancer and utilizing its contract research organization (CRO) independent product development platform to partner with other life science companies to develop and commercialize products in the United States. The Company’s clinical-stage oncology product candidate is TRC102, which is a small molecule that has been studied in Phase 1 and Phase 2 trials for the treatment of mesothelioma, lung cancer, glioblastoma and solid tumors and YH001, which is a monospecific investigational cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) antibody. TRC102 is a small molecule in clinical development to reverse resistance to specific chemotherapeutics by inhibiting DNA base excision repair (BER). Its clinical-stage product candidate, Envafolimab, is a PD-L1 antibody that is being developed for the treatment of sarcoma.